Fiorinal

   
Google
 
Web NewDrugInformation.com

Fiorinal


Drug - Fiorinal
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Aspirin; Butalbital; Caffeine
Multiple ingredients are in alphabetical order.

Strength - 325MG;50MG;40MG
The potency of the active ingredient(s), Aspirin; Butalbital; Caffeine. May repeat for multiple part products.

Applicant - WATSON PHARMS
The firm name holding legal responsibility for Fiorinal. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017534
The FDA assigned number to Fiorinal. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Fiorinal. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 16, 1986
The date Fiorinal was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Fiorinal. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Fiorinal is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Fiorinal.

Fiorinal